SIGA Technologies, Inc.
(NASDAQ : SIGA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-0.58%15.471.8%$136.86m
VRXValeant Pharmaceuticals International, Inc.
-1.77%21.7114.1%$127.74m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.22%147.036.2%$79.06m
PRGOPerrigo Co. Plc
-1.93%46.856.8%$68.74m
SAGESAGE Therapeutics, Inc.
1.60%171.828.6%$67.78m
JAZZJazz Pharmaceuticals Plc
-0.16%130.612.3%$52.40m
HZNPHorizon Pharma plc
0.11%27.716.7%$43.91m
PTLAPortola Pharmaceuticals, Inc.
0.26%28.897.5%$42.14m
UTHRUnited Therapeutics Corporation
-0.18%82.7014.3%$41.51m
MDCOMedicines Company
0.73%36.0520.3%$39.32m
ICLRICON Plc
0.15%156.554.1%$37.28m
CTLTCatalent Inc
-0.93%54.732.4%$35.61m
ICPTIntercept Pharmaceuticals, Inc.
-0.06%62.9517.2%$33.75m
AERIAerie Pharmaceuticals, Inc.
-0.10%23.956.8%$24.53m
PCRXPacira Pharmaceuticals, Inc.
-1.98%37.1910.5%$23.78m

Company Profile

SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded on December 28, 1995 and is headquartered in New York, NY.